B0099
BRCA1 and BRCA2 Germline Variant Testing
Test Details: Germline pathogenic variants (PVs) in the BRCA1 and BRCA2 genes confer a significantly increased lifetime risk for the development of both breast and ovarian cancer. This assay is useful for screening family members of known Breast cancer patients. The test consists of sequencing and large rearrangement analyses of the BRCA1 and BRCA2 genes using next-generation sequencing (NGS).
![](assets/img/diagnleftimg.png)
Category
Molecular Genetics
Pre-test Information
Clinical details & history is mandatory.
Report Delivery
16 working days
Gender
All
Organ
Breast
BRCA1 and BRCA2 Germline Variant Testing
20000
Most Searched Diagnostic Tests